MIRM Exercise Disclosure
Peetz Christopher · SEC Form 4 · Filed Nov 4, 2026
Exercise
Calculated transaction value
$0
Peetz Christopher Chief Executive Officer
MIRM
Transaction date
Nov 4, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed same day
MIRM daily price context
Close on/before transaction
$96.97
Nov 4, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 20,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001614740-26-000015
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.86M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. MIRM | Sale | Nov 4, 2026 | $1.8M |
| Mirum Pharmaceuticals, Inc. MIRM | Exercise | Nov 4, 2026 | $58.72K |
| Mirum Pharmaceuticals, Inc. MIRM Current | Exercise | Nov 4, 2026 | $0 |